BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3560 related articles for article (PubMed ID: 2414367)

  • 1. Anti-T4-tyrosinase monoclonal antibodies--specific markers for pigmented melanocytes.
    Tomita Y; Montague PM; Hearing VJ
    J Invest Dermatol; 1985 Nov; 85(5):426-30. PubMed ID: 2414367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies produced against murine tyrosinase identify pigmented human melanocytes.
    Tomita Y; Hearing VJ
    Diagn Immunol; 1986; 4(3):149-54. PubMed ID: 3089671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibody against human tyrosinase and reactive with melanotic and amelanotic melanoma cells.
    McEwan M; Parsons PG; Moss DJ
    J Invest Dermatol; 1988 Apr; 90(4):515-9. PubMed ID: 3127479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The monoclonal antibodies TMH-1 and TMH-2 specifically bind to a protein encoded at the murine b-locus, not to the authentic tyrosinase encoded at the c-locus.
    Tomita Y; Shibahara S; Takeda A; Okinaga S; Matsunaga J; Tagami H
    J Invest Dermatol; 1991 Apr; 96(4):500-4. PubMed ID: 1706745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibody against a melanosomal protein in melanotic and amelanotic human melanoma cells.
    McEwan M; Parsons PG; Moss DJ; Burrows S; Stenzel D; Bishop CJ; Strutton GM
    Pigment Cell Res; 1989; 2(1):1-7. PubMed ID: 2470076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoelectron microscopic demonstration of human melanosome associated antigens (HMSA) on melanoma cells: comparison with tyrosinase distribution.
    Akutsu Y; Jimbow K
    J Invest Dermatol; 1988 Feb; 90(2):179-84. PubMed ID: 3123559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of pigmentation in mouse fibroblasts by expression of human tyrosinase cDNA.
    Bouchard B; Fuller BB; Vijayasaradhi S; Houghton AN
    J Exp Med; 1989 Jun; 169(6):2029-42. PubMed ID: 2499655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactivity to tyrosinase: expression in cancer (melanoma) and autoimmunity (vitiligo).
    Merimsky O; Shoenfeld Y; Baharav E; Zigelman R; Fishman P
    Hum Antibodies Hybridomas; 1996; 7(4):151-6. PubMed ID: 9140726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of melanocyte-specific antibodies to human melanosomal proteins: expression patterns in normal human skin and in cutaneous pigmented lesions.
    Virador V; Matsunaga N; Matsunaga J; Valencia J; Oldham RJ; Kameyama K; Peck GL; Ferrans VJ; Vieira WD; Abdel-Malek ZA; Hearing VJ
    Pigment Cell Res; 2001 Aug; 14(4):289-97. PubMed ID: 11549113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mammalian tyrosinase: biosynthesis, processing, and modulation by melanocyte-stimulating hormone.
    Jiménez M; Kameyama K; Maloy WL; Tomita Y; Hearing VJ
    Proc Natl Acad Sci U S A; 1988 Jun; 85(11):3830-4. PubMed ID: 3131764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-tyrosinase antibodies participate in the immune response to vaccination with anti-idiotypic antibodies mimicking the high-molecular-weight melanoma-associated antigen.
    Baharav E; Merimsky O; Altomonte M; Shoenfeld Y; Pavlovic M; Maio M; Ferrone S; Fishman P
    Melanoma Res; 1995 Oct; 5(5):337-43. PubMed ID: 8541724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of mouse tyrosinase with a monoclonal antibody MAT-1 against human tyrosinase.
    Suzuki S; Takimoto H; Masui S; Kato T; Shibata K; Tomita Y; Shibahara S; Nakano H
    Pigment Cell Res; 1996 Dec; 9(6):298-303. PubMed ID: 9125753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific inhibition by antityrosinase antibodies of tyrosinase-mediated melanogenesis.
    Vachtenheim J; Duchon J; Matous B; Vulterin K
    J Invest Dermatol; 1986 May; 86(5):573-6. PubMed ID: 3091707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of tyrosinase levels in amelanotic and melanotic melanoma cell cultures by a competitive enzyme-linked immunoadsorbent assay and by immunotitration analysis.
    Fuller BB; Iman DS; Lunsford JB
    J Cell Physiol; 1988 Jan; 134(1):149-54. PubMed ID: 3121644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MAT-1, a monoclonal antibody that specifically recognizes human tyrosinase.
    Takimoto H; Suzuki S; Masui S; Shibata K; Tomita Y; Shibahara S; Nakano H
    J Invest Dermatol; 1995 Dec; 105(6):764-8. PubMed ID: 7490469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning and expression of cDNA encoding mouse tyrosinase.
    Shibahara S; Tomita Y; Sakakura T; Nager C; Chaudhuri B; Müller R
    Nucleic Acids Res; 1986 Mar; 14(6):2413-27. PubMed ID: 3008090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative analysis of mouse tyrosinase by enzyme-linked immunosorbent assay.
    Ishiguro S; Yamamoto H; Yanai N; Takeuchi T
    J Biochem; 1986 Apr; 99(4):1081-5. PubMed ID: 3086301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of tyrosinase in human melanocytes grown in culture.
    Halaban R; Pomerantz SH; Marshall S; Lambert DT; Lerner AB
    J Cell Biol; 1983 Aug; 97(2):480-8. PubMed ID: 6411733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunophenotyping of melanomas for tyrosinase: implications for vaccine development.
    Chen YT; Stockert E; Tsang S; Coplan KA; Old LJ
    Proc Natl Acad Sci U S A; 1995 Aug; 92(18):8125-9. PubMed ID: 7667256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production and characterization of the murine monoclonal antibody 2G10 to a human T4-tyrosinase epitope.
    Cuomo M; Nicotra MR; Apollonj C; Fraioli R; Giacomini P; Natali PG
    J Invest Dermatol; 1991 Apr; 96(4):446-51. PubMed ID: 1706743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 178.